George Milne

George Mclean Milne currently works at Mystic Aquarium & Institute for Exploration, as Chairman, Amylyx Pharmaceuticals, Inc., as Chairman from 2021, Charles River Laboratories, Inc., as Independent Director from 2002, Sea Research Foundation, Inc., as Director from 2002, Radius Ventures LLC, as Venture Partner from 2003, and The New York Botanical Garden, as Trustee from 1998.
Dr. Milne also formerly worked at Melinta Subsidiary Corp., as Chairman from 2004 to 2013, Aurinia Pharmaceuticals, Inc., as Chairman from 2019 to 2023, MedImmune LLC, as Director from 2005 to 2007, QLT, Inc., as Independent Director, Mettler-Toledo International, Inc., as Independent Director from 2011 to 2016, Charles River Laboratories International, Inc., as Lead Independent Director from 2002 to 2022, Conor Medsystems LLC, as Director from 2003 to 2006, Aspreva Pharmaceuticals Corp., as Lead Director from 2004 to 2007, BTHC VI, Inc., as Director in 2007, Resolvyx Pharmaceuticals, Inc., as Director, Athersys, Inc., as Independent Director from 2011 to 2012, BioStorage Technologies, Inc., as Director from 2007 to 2019, The Charles Stark Draper Laboratory, Inc., as Director from 2007 to 2024, Mettler Toledo, Inc., as Director from 1999 to 2016, and Pfizer Inc., as President-Central Research from 1993 to 2002.
Dr. Milne received his doctorate degree from Massachusetts Institute of Technology and undergraduate degree from Yale University.